PPH ETF

$104.79
Screen 3,400+ ETFsFind similar ETFs with lower fees

Returns Overview

1 Month
+4.61%
3 Months
+9.24%
6 Months
+26.56%
YTD
+7.72%
1 Year
+21.64%
3 Years
+16.18%
5 Years
+12.69%
10 Years
+8.96%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would PPH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+4.61%

3 Months Performance

+9.24%

6 Months Performance

+26.56%

1 Year Performance

+21.64%

Benchmark & Peers

Benchmark
MVIS US Listed Pharmaceutical 25 Index(^MVPPH)
This ETF (YTD)
+7.72%
Peer Avg (YTD)
+1.55%
vs Peers
+6.17%

PPH ETF Performance

PPH performance across multiple time periods: 1-month 4.61%, YTD 7.72%, 1-year 21.64%, 3-year 16.18%, 5-year 12.69%, 10-year 8.96%.

PPH returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.36%, investors should weigh costs against performance when evaluating this ETF.

PPH performance comparison shows side-by-side returns with another fund. PPH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+4.61%N/A
3 Months+9.24%N/A
6 Months+26.56%N/A
1 Year+21.64%N/A
3 Years+16.18%N/A
5 Years+12.69%N/A

All returns shown are total returns, not annualized